ATE292282T1 - Verfahren zur zellseparation unter verwendung von immunorosetten - Google Patents

Verfahren zur zellseparation unter verwendung von immunorosetten

Info

Publication number
ATE292282T1
ATE292282T1 AT00930932T AT00930932T ATE292282T1 AT E292282 T1 ATE292282 T1 AT E292282T1 AT 00930932 T AT00930932 T AT 00930932T AT 00930932 T AT00930932 T AT 00930932T AT E292282 T1 ATE292282 T1 AT E292282T1
Authority
AT
Austria
Prior art keywords
cells
immunorosets
cell separation
immunorosettes
red blood
Prior art date
Application number
AT00930932T
Other languages
English (en)
Inventor
Terry E Thomas
Carrie Peters
Peter Lansdorp
Original Assignee
Stemcell Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stemcell Technologies Inc filed Critical Stemcell Technologies Inc
Application granted granted Critical
Publication of ATE292282T1 publication Critical patent/ATE292282T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/31—Immunoglobulins specific features characterized by aspects of specificity or valency multispecific

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Ecology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT00930932T 1999-05-28 2000-05-26 Verfahren zur zellseparation unter verwendung von immunorosetten ATE292282T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US13677099P 1999-05-28 1999-05-28
US19337100P 2000-03-31 2000-03-31
US20347700P 2000-05-11 2000-05-11
PCT/CA2000/000616 WO2000073794A2 (en) 1999-05-28 2000-05-26 Method for separating cells using immunorosettes

Publications (1)

Publication Number Publication Date
ATE292282T1 true ATE292282T1 (de) 2005-04-15

Family

ID=27384918

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00930932T ATE292282T1 (de) 1999-05-28 2000-05-26 Verfahren zur zellseparation unter verwendung von immunorosetten

Country Status (11)

Country Link
US (2) US6448075B1 (de)
EP (1) EP1185867B1 (de)
JP (1) JP4526749B2 (de)
CN (1) CN1218182C (de)
AT (1) ATE292282T1 (de)
AU (1) AU769903B2 (de)
CA (1) CA2375115C (de)
DE (1) DE60019111T2 (de)
HK (1) HK1044819B (de)
IL (2) IL146660A0 (de)
WO (1) WO2000073794A2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7135335B2 (en) * 1999-05-28 2006-11-14 Stemcell Technologies Inc. Method for separating cells using immunorosettes
US20030157060A1 (en) * 2000-04-03 2003-08-21 Bell David N Production of tcr gamma delta t cells
US7205157B2 (en) * 2001-01-08 2007-04-17 Becton, Dickinson And Company Method of separating cells from a sample
DE60238801D1 (de) * 2001-04-10 2011-02-10 Bioe Llc Zelltrennungszusammensetzungen und -verfahren
US6667022B2 (en) * 2001-08-14 2003-12-23 General Electric Co. Process for separating synthesis gas into fuel cell quality hydrogen and sequestration ready carbon dioxide
CA2499826C (en) * 2002-09-27 2015-03-24 Bioe, Inc. Cell separation compositions and methods
EP1574583A1 (de) * 2004-03-10 2005-09-14 Roche Diagnostics GmbH Verfahren zur Isolierung von Bakterien aus biologischen Proben
EP1574584B1 (de) * 2004-03-10 2006-11-15 Boehringer Mannheim Gmbh Verfahren zur Isolierung von Bakterien aus biologischen Proben
US7622108B2 (en) * 2004-04-23 2009-11-24 Bioe, Inc. Multi-lineage progenitor cells
CA2563518C (en) * 2004-04-23 2014-09-02 Bioe, Inc. Multi-lineage progenitor cells
US8263404B2 (en) * 2005-04-08 2012-09-11 Medical Discovery Partners Llc Method for enriching rare cell subpopulations from blood
CA2640185A1 (en) * 2006-01-24 2007-08-02 Christopher J. Centeno Mesenchymal stem cell isolation and transplantation method and system to be used in a clinical setting
US7727763B2 (en) * 2006-04-17 2010-06-01 Bioe, Llc Differentiation of multi-lineage progenitor cells to respiratory epithelial cells
KR100833793B1 (ko) * 2006-05-16 2008-05-29 세원셀론텍(주) 골수 유래 골 생성용 유핵 세포 분리 방법
US7862813B2 (en) * 2006-07-29 2011-01-04 Bjork Jr Robert Lamar Bi-specific monoclonal antibody (specific for both CD3 and CD11b) therapeutic drug
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
US8574567B2 (en) * 2007-05-03 2013-11-05 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
WO2008137115A1 (en) 2007-05-03 2008-11-13 The Brigham And Women's Hospital, Inc. Multipotent stem cells and uses thereof
US9095562B2 (en) 2007-07-05 2015-08-04 Regenerative Sciences, Inc. Methods and compositions for optimized expansion and implantation of mesenchymal stem cells
EP2192908A4 (de) * 2007-07-25 2010-09-01 Bioe Inc Differenzierung von vorläuferzellen mehrerer abstammung gegenüber chondrozyten
US20110200642A1 (en) * 2007-12-19 2011-08-18 Regenerative Sciences, Llc Compositions and Methods to Promote Implantation and Engrafment of Stem Cells
US20110052533A1 (en) * 2008-03-14 2011-03-03 Regenerative Sciences, Llc Compositions and Methods for Cartilage Repair
CA2724839A1 (en) * 2008-05-21 2009-11-26 Bioe Llc Differentiation of multi-lineage progenitor cells to pancreatic cells
JP2012510874A (ja) 2008-12-05 2012-05-17 リジェネレイティブ サイエンシーズ， エルエルシー 無血管組織の修復を促進するための方法及び組成物
US20100168022A1 (en) * 2008-12-11 2010-07-01 Centeno Christopher J Use of In-Vitro Culture to Design or Test Personalized Treatment Regimens
JP5660035B2 (ja) * 2009-04-28 2015-01-28 コニカミノルタ株式会社 融合タンパク質含有集合体、その製造方法及び該集合体を用いたアッセイ法
US20110054929A1 (en) * 2009-09-01 2011-03-03 Cell Solutions Colorado Llc Stem Cell Marketplace
US9113950B2 (en) 2009-11-04 2015-08-25 Regenerative Sciences, Llc Therapeutic delivery device
BR112012018166A2 (pt) 2010-01-21 2015-09-15 Biocep Ltd separação magnética de células raras.
FR2963108B1 (fr) * 2010-07-21 2017-06-23 Diagast Procede magnetique d'immunodiagnostic et kit pour la mise en evidence de complexe anticorps/antigene de groupe/phenotype sanguin
WO2012018930A1 (en) * 2010-08-03 2012-02-09 University Of Miami Methods of isolating and expanding human t regulatory cells and uses thereof for cellular therapy
US9850296B2 (en) 2010-08-10 2017-12-26 Ecole Polytechnique Federale De Lausanne (Epfl) Erythrocyte-binding therapeutics
EP2652499B1 (de) * 2010-12-15 2019-08-07 Cytosed, Inc. Antikörpergebundenes immunsedimentationsmittel und verfahren zur isolierung eines ziels aus einer probe damit
US9133438B2 (en) 2011-06-29 2015-09-15 Biorestorative Therapies, Inc. Brown fat cell compositions and methods
ES2602500T3 (es) 2011-11-25 2017-02-21 Miltenyi Biotec Gmbh Método de separación celular
DE102012003700B3 (de) * 2012-02-28 2012-11-29 FLACOD GmbH Verfahren zur Trennung von Verbänden maligner Zellen und Verbänden aus Stromazellen einer Malignomgewebeprobe
US8921055B2 (en) 2012-10-30 2014-12-30 Berkeley Lights, Inc. Detecting cells secreting a protein of interest
EP2970906B1 (de) 2013-03-15 2019-08-21 Stemcell Technologies Inc. Verfahren zur zellseparation unter verwendung von immunorosetten und magnetischen teilchen
US11221325B2 (en) 2013-09-30 2022-01-11 Sekisui Medical Co., Ltd. Device for concentration and separation of circulating tumor cells, and method for concentration and separation of circulating tumor cells
CA2936914C (en) 2014-01-21 2020-08-18 Stemcell Technologies Inc. Method for separating target entities from a sample using a composition of mono-specific tetrameric antibody complexes coupled to a surface
CN106687584B (zh) * 2014-09-04 2021-08-13 干细胞技术公司 用于t细胞或nk细胞活化和扩增的可溶性抗体复合物
GB201418382D0 (en) * 2014-10-16 2014-12-03 Ge Healthcare Uk Ltd Device and method for separating cells
EP3037170A1 (de) 2014-12-27 2016-06-29 Miltenyi Biotec GmbH Multisort-Zelltrennverfahren
WO2016122014A1 (ko) * 2015-01-27 2016-08-04 한국생명공학연구원 자연살해세포의 대량생산 방법 및 상기 방법으로 수득된 자연살해세포의 항암제로서의 용도
US12398371B2 (en) 2015-01-27 2025-08-26 Korea Research Institute Of Bioscience Method for mass producing natural killer cell and use of natural killer cell obtained by the method as anti-cancer agent
US10983114B2 (en) 2015-06-10 2021-04-20 Stemcell Technologies Inc. Method for the in situ formation of bifunctional immunological complexes
JP6779483B2 (ja) 2016-09-29 2020-11-04 住友ゴム工業株式会社 医療用検査装置及び細胞検査方法
WO2018170335A1 (en) * 2017-03-15 2018-09-20 Orca Biosystems Inc. Compositions and methods for hematopoietic stem cell transplants
JP7109719B2 (ja) * 2018-02-14 2022-08-01 住友ゴム工業株式会社 特定細胞捕捉方法
WO2019215590A1 (en) * 2018-05-07 2019-11-14 Anokion Sa Glycophorin a antigen-binding proteins
CN112469816A (zh) * 2018-06-06 2021-03-09 加拿大干细胞技术公司 用于富集髓系来源的抑制细胞的试剂盒、组合物和方法
US11614440B2 (en) 2019-01-24 2023-03-28 Sumitomo Rubber Industries, Ltd. Specific cell fractionating and capturing methods
US11725042B2 (en) 2019-06-27 2023-08-15 Stemcell Technologies Canada Inc. Methods and devices for complexing target entities
US12486492B2 (en) 2020-03-05 2025-12-02 Korea Research Institute Of Bioscience Method for producing memory-like NK cells with ability to express higher levels of NCRs, cytotoxicity, and IFN-γ than NK cells in human peripheral blood

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8501219A (nl) * 1985-04-29 1986-11-17 Stichting Vrienden Van De Stic Immunologisch complex, de bereiding en toepassing daarvan.
LU86752A1 (fr) * 1987-01-30 1988-08-23 Univ Bruxelles Procede de production d'anticorps monoclonaux humains(igg)anticytomegalovirus et anticorps monoclonaux ainsi obtenus
US5086002A (en) * 1987-09-07 1992-02-04 Agen Biomedical, Ltd. Erythrocyte agglutination assay
AU8869291A (en) * 1990-10-04 1992-04-28 University Of Virginia Alumni Patents Foundation, The Primate erythrocyte bound monoclonal antibody heteropolymers
US5374531A (en) * 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
JP3331398B2 (ja) * 1993-05-28 2002-10-07 バクスター、インターナショナル、インコーポレイテッド 不均質な細胞混合物から特定の細胞集団を分離するための方法、装置およびシステム
US6306575B1 (en) * 1995-06-16 2001-10-23 Stemcell Technologies, Inc. Methods for preparing enriched human hematopoietic cell preparations
US6117985A (en) * 1995-06-16 2000-09-12 Stemcell Technologies Inc. Antibody compositions for preparing enriched cell preparations
US5877299A (en) * 1995-06-16 1999-03-02 Stemcell Technologies Inc. Methods for preparing enriched human hematopoietic cell preparations
DE19710496A1 (de) * 1997-03-13 1998-09-17 Boehringer Mannheim Gmbh Verfahren zum Nachweis antigenspezifischer T-Zellen nach Anreicherung von mononukleären Zellpopulationen
US6572856B1 (en) * 1998-09-10 2003-06-03 The University Of Virginia Patent Foundation Methods for the prevention and treatment of cancer using anti-C3b(i) antibodies

Also Published As

Publication number Publication date
US6448075B1 (en) 2002-09-10
JP2003501629A (ja) 2003-01-14
CN1367876A (zh) 2002-09-04
EP1185867A2 (de) 2002-03-13
US20030092078A1 (en) 2003-05-15
CA2375115A1 (en) 2000-12-07
DE60019111T2 (de) 2006-01-26
CN1218182C (zh) 2005-09-07
AU4905900A (en) 2000-12-18
HK1044819A1 (en) 2002-11-01
HK1044819B (en) 2005-07-29
WO2000073794A3 (en) 2001-08-30
EP1185867B1 (de) 2005-03-30
IL146660A (en) 2007-10-31
JP4526749B2 (ja) 2010-08-18
WO2000073794A2 (en) 2000-12-07
IL146660A0 (en) 2002-07-25
DE60019111D1 (de) 2005-05-04
CA2375115C (en) 2011-05-24
AU769903B2 (en) 2004-02-05
US6872567B2 (en) 2005-03-29

Similar Documents

Publication Publication Date Title
ATE292282T1 (de) Verfahren zur zellseparation unter verwendung von immunorosetten
ATE187501T1 (de) Verfahren zur erkennung von ligandenpaar bindung mit erhöter empfindlichkeit
DE602005013957D1 (de) Verfahren zur durchführung von vollbluttests
GB2374415B (en) Human antibodies as detection reagents
DE3851967D1 (de) Verfahren zur Bestimmung von Antikörpern.
ATE516492T1 (de) Vorrichtung und verfahren zur multianalytbestimmung
DE69626418D1 (de) Verfahren zur bulk-anreicherung von einer zellpopulation oder zellsubpopulation
ATE441846T1 (de) Hämatologische referenzkontrolle und verfahren zur herstellung
ATE85131T1 (de) Verfahren zur spezifischen bestimmung des serumfructosamingehalts sowie hierfuer geeignetes reagenzgemisch.
DE3486350D1 (de) VERFAHREN ZUR ISOLIERUNG EINES PROTEINS AUS EINER DIESES PROTEIN ENTHALTENDEN MISCHUNG UNTER VERWENDUNG EINES KONFORMATIONSSPEZIFISCHEN ANTIKöRPERS.
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
FI925781A0 (fi) Analys av analytvarianter
DE69323589D1 (de) Einen Basophilen bindender monoclonaler Antikörper, Verfahren zur Abtrennung von Basophilen, Verfahren für die Freisetzung von chemischen Vermittlern aus Basophilen, und Verfahren zur Prüfung der Freisetzung von von Basophilen abgeleiteten chemischen Vermittlern
ATE48037T1 (de) Verfahren und reagenz zur verwendung zur bestimmung von pivka-ii.
ATE185900T1 (de) Festphasen-filtrationsverfahren zur antigen- und antikörperprüfung in der blutgruppen-serologie, und testsatz
BR9808219A (pt) Processos de identificação e de isolamento de glóbulos vermelhos fetais ou embriÈnicos e de determinação de uma anormalidade fetal, kit de partes para determinação de uma anormalidade fetal e uso de uma unidade de ligação e de um meio
DE69633740D1 (de) Verfahren zur auswahl einer population oder subpopulation einer probe unter verwendung von partikel-und schwerkraft -sedimentation
DE602005000249D1 (de) Verfahren zur Isolierung von Bakterien aus biologischen Proben
DK426588A (da) Fremgangsmaade til paavisning af celleoverfladeantigen
DE69737329D1 (de) Synthetische biepitopische zusammensetzungen zur verwendung als kalibratoren bei der biologischen bestimmung von troponin i
ATE530909T1 (de) Immunologisches testsystem und -verfahren
WO1998029726A3 (en) Method of detecting and determining the concentration of total troponin i in a biological sample
ATE132896T1 (de) Methoden zur verwendung von an humanen klasse-ii- histokompatibilitätsantigenen mangelnden zellinien
ATE68598T1 (de) Verfahren und zusammensetzung zur abtrennung von weissen blutkoerperchenelementen.
JP2009014572A (ja) ヒト赤血球が固相化されたクロスマッチ試験用容器の製造方法

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties